FSNUY Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA Reported Earnings
Fresenius SE & Co. KGaA (FSNUY) reported earnings of $0.25 per share on revenue of $6.77 billion for the third quarter ended September 2026. . Revenue grew 5.61% on a year-over-year basis.
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.